Posted on January 4th, 20191/4/19
EVERSANA, the leading independent provider of global services to the life science industry, is proud to join the rare disease community as a sponsor of Global Genes’ RARE in the Square, which connects rare disease stakeholders as they strive to eliminate the challenges of rare disease.
RARE in the Square coincides with the JP Morgan Healthcare Conference in San Francisco, California, January 7. Investors, industry partners, patient community leaders and influencers — all who share a commitment to helping the more than 350 million people impacted by rare disease — will gather to collaborate about innovation and therapeutics.
“We share Global Genes’ pursuit of building better lives for patients with rare disease,” shared Kathi Henson, Patient Services President, EVERSANA. “Our integrated platform is building stronger patient relationships, increasing adherence, and supporting healthier outcomes for the millions living with rare diseases.”
EVERSANA provides a unique wrap-around patient-service model for patients with rare disease, guiding them every step of the way. Our dedicated team helps support a faster onboarding process, identifies affordability solutions, and drives the highest possible adherence for our patients– all through a single point of contact.
EVERSANA is proud to support Global Genes’ mission to connect, empower, and inspire the rare disease community — a mission we share. To date, Global Genes has educated 6 million people in 100 countries about rare disease, equipped 30,000 patients and advocates with tools and resources, and provided $400,000 in support for innovative patient impact programs.
Posted on October 15th, 201810/15/18
A team of EVERSANA experts will be in Washington, DC today for the National Organization for Rare Disorders’ (NORD) 2018 Rare Summit. They will join more than 700 leaders from the FDA, NIH, industry, patient groups, payers and research institutions to address the industry’s shift to patient-centered, value-based care. “We’re proud of our long standing […]
Posted on October 3rd, 201810/3/18
CHICAGO – October 3, 2018 – EVERSANA,™ the leading independent provider of global services to the life science industry, today announced the addition of Seeker Health® to its platform. Headquartered in Palo Alto, Calif., Seeker Health offers breakthrough digital patient identification technology to accelerate drug development and commercialization for biopharmaceutical companies. The company excels at […]
Posted on October 2nd, 201810/2/18
EVERSANA, the leading independent provider of global services to the life science industry, is proud to join the rare disease patient community as a sponsor of the Global Genes 2018 RARE Patient Advocacy Summit in Irvine, California, October 3-4. The event is the largest gathering of rare disease patients, advocates and thought leaders, who share […]
Posted on September 30th, 20189/30/18
MILWAUKEE – October 1, 2018 – The fast-growing life science services platform built in partnership with Water Street Healthcare Partners and JLL Partners, today unveiled its new name and brand: EVERSANA.™ Anchored to the Latin word “sana” for healthy and “ever” for continual evolution, the new name reflects the expanding platform’s commitment to advancing life […]